跳轉至內容
Merck
全部照片(1)

重要文件

AB1857

Sigma-Aldrich

Anti-Osteocalcin Antibody, a.a. 1-22

serum, Chemicon®

同義詞:

Anti-BGP

登入查看組織和合約定價


About This Item

分類程式碼代碼:
12352203
eCl@ss:
32160702
NACRES:
NA.41

生物源

rabbit

品質等級

抗體表格

serum

抗體產品種類

primary antibodies

無性繁殖

polyclonal

物種活性

human

製造商/商標名

Chemicon®

技術

ELISA: suitable
radioimmunoassay: suitable

NCBI登錄號

UniProt登錄號

運輸包裝

wet ice

目標翻譯後修改

unmodified

基因資訊

human ... BGLAP(632)

特異性

Recognizes human osteocalcin (1-22) mature form. Also reacts with osteocalcin (1-44) and osteocalcin (1-49). No reactivity with human bone sialoprotein and human osteonectin.

免疫原

Epitope: a.a. 1-22
Synthetic peptide corresponding to amino acids 1-22 of human Osteocalcin (MRALTLLALLALAALCIAGQAG).

應用

Anti-Osteocalcin Antibody, a.a. 1-22 detects level of Osteocalcin & has been published & validated for use in ELISA, RIA.
RIA (1:2000)

ELISA (1:5000)

Optimal working dilutions must be determined by the end user.
Research Category
Neuroscience
Research Sub Category
Hormones & Receptors

聯結

Replaces: MABD182

外觀

Rabbit serum. Lyophilized. Reconstitute with 100 μL of sterile distillled water.

儲存和穩定性

Maintain lyophilized material at 2-8°C. After reconstitution maintain at -20°C in undiluted aliquots for up to 6 months. Avoid repeated freeze/thaw cycles.

法律資訊

CHEMICON is a registered trademark of Merck KGaA, Darmstadt, Germany

免責聲明

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.

未找到適合的產品?  

試用我們的產品選擇工具.

儲存類別代碼

10 - Combustible liquids


分析證明 (COA)

輸入產品批次/批號來搜索 分析證明 (COA)。在產品’s標籤上找到批次和批號,寫有 ‘Lot’或‘Batch’.。

已經擁有該產品?

您可以在文件庫中找到最近購買的產品相關文件。

存取文件庫

Nanocomposite Ti/hydrocarbon plasma polymer films from reactive magnetron sputtering as growth support for osteoblast-like and endothelial cells.
Andrey Grinevich,Lucie Bacakova,Andrei Choukourov,Hanna Boldyryeva,Yuriy Pihosh et al.
Journal of Biomedical Materials Research Part A null
Laurent A Tchang et al.
Journal of tissue engineering and regenerative medicine, 11(5), 1542-1552 (2015-06-17)
The use of fetal bovine serum (FBS) as a culture medium supplement in cell therapy and clinical tissue engineering is challenged by immunological concerns and the risk of disease transmission. Here we tested whether human, thrombin-activated, pooled, platelet-rich plasma (tPRP)
Huawen Ding et al.
Journal of cell science, 125(Pt 22), 5564-5577 (2012-09-05)
Nitric oxide (NO) has been shown to play a crucial role in bone formation in vivo. We sought to determine the temporal effect of NO on murine embryonic stem cells (ESCs) under culture conditions that promote osteogenesis. Expression profiles of
Differentiation of mesenchymal stem cells onto highly adherent radio frequency-sputtered carbonated hydroxylapatite thin films.
Sima, Livia E, et al.
Journal of Biomedical Materials Research Part A, 95, 1203-1214 (2010)
Elena Filová et al.
International journal of nanomedicine, 9, 3687-3706 (2014-08-16)
Hydroxyapatite (HA) is considered to be a bioactive material that favorably influences the adhesion, growth, and osteogenic differentiation of osteoblasts. To optimize the cell response on the hydroxyapatite composite, it is desirable to assess the optimum concentration and also the

我們的科學家團隊在所有研究領域都有豐富的經驗,包括生命科學、材料科學、化學合成、色譜、分析等.

聯絡技術服務